questionText: To ask the Secretary of State for Health and Social Care, with reference to page 75 of the policy paper entitled A National Cancer Plan for England: delivering world class cancer care, whether it is his policy that patients with rare cancers should be offered targeted and personalised therapies where genomic testing identifies a suitable potential treatment.
answerText: The National Cancer Plan, published on 4 February 2026, sets out clear actions to expand diagnostic genomic testing and ensure that this is matched by access to targeted therapies. The plan confirms that every cancer patient who would benefit from genomic...
heading: Rare Cancers: Health Services